Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy.

@article{Ohta2001WholeBP,
  title={Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy.},
  author={Marie Ohta and Yutaka Tokuda and Maki Kubota and Hiroyasu Makuuchi and Tomoo Tajima and Saiko Nasu and Yasuyuki Suzuki and Seiei Yasuda and Akira Shohtsu},
  journal={Nuclear medicine communications},
  year={2001},
  volume={22 8},
  pages={875-9}
}
The purpose of this study was to determine the potential role of positron emission tomography (PET) using 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) for the evaluation of bony metastasis compared with 99Tcm-methylene diphosphonate (99Tcm-MDP) bone scintigraphy in patients with breast cancer. Fifty-one female patients with breast cancer who had PET together with a bone scan within 1 month between September 1994 and March 1997 were included in this study. The median age was 49 years (range 29-79… CONTINUE READING
53 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

Similar Papers

Loading similar papers…